126 related articles for article (PubMed ID: 34456294)
1. Antibodies to EGF Receptor Family Members Can Upregulate Tumor Immunity.
Dai M; Yip YY; Todaro G; Hellstrom I; Hellstrom KE
J Immunother; 2021 Nov-Dec 01; 44(9):355-361. PubMed ID: 34456294
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
Ciardiello F; Damiano V; Bianco R; Bianco C; Fontanini G; De Laurentiis M; De Placido S; Mendelsohn J; Bianco AR; Tortora G
J Natl Cancer Inst; 1996 Dec; 88(23):1770-6. PubMed ID: 8944008
[TBL] [Abstract][Full Text] [Related]
4. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
5. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
Modjtahedi H; Styles JM; Dean CJ
Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
[TBL] [Abstract][Full Text] [Related]
6. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
7. Inability of anti-epidermal growth factor receptor monoclonal antibody to block "autocrine" growth stimulation in transforming growth factor-secreting melanoma cells.
Kudlow JE; Khosravi MJ; Kobrin MS; Mak WW
J Biol Chem; 1984 Oct; 259(19):11895-900. PubMed ID: 6090450
[TBL] [Abstract][Full Text] [Related]
8. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors.
Yoshida K; Kyo E; Tsuda T; Tsujino T; Ito M; Niimoto M; Tahara E
Int J Cancer; 1990 Jan; 45(1):131-5. PubMed ID: 2298497
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor.
Modjtahedi H; Eccles SA; Box G; Styles J; Dean CJ
Cell Biophys; 1993; 22(1-3):129-46. PubMed ID: 7534211
[TBL] [Abstract][Full Text] [Related]
10. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies.
Dai M; Yip YY; Hellstrom I; Hellstrom KE
Clin Cancer Res; 2015 Mar; 21(5):1127-38. PubMed ID: 25142145
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
12. Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agents.
Mendelsohn J
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):889-92. PubMed ID: 2285602
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
J Natl Cancer Inst Monogr; 1992; (13):125-31. PubMed ID: 1389685
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
Rodeck U; Williams N; Murthy U; Herlyn M
J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
[TBL] [Abstract][Full Text] [Related]
16. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells.
Taetle R; Honeysett JM; Houston LL
J Natl Cancer Inst; 1988 Sep; 80(13):1053-9. PubMed ID: 3261802
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.
Ahmed SR; Badger B; Wright C; Manni A
J Steroid Biochem Mol Biol; 1991 Jun; 38(6):687-93. PubMed ID: 2064983
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
